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Summary
Objective:  The  study  was  conducted  to  determine  the  association  of  the  hlyD, papC
and  cnf-1  virulence  genes  with  drug  resistance  in  uropathogenic  Escherichia  coli
(UPEC)  isolated  from  cases  of  urinary  tract  infection  (UTI).
Method:  A  total  of  193  E.  coli  strains  isolated  from  symptomatic  cases  of  UTI
in  a  tertiary  care  teaching  hospital  in  Raichur,  Northern  Karnataka,  India  were
included  in  the  study.  The  antibiotic  susceptibility  pattern  was  determined  by
Kirby—Bauer’s  Disk  Diffusion  method,  and  the  strains  resistant  to  any  of  the  third
generation  cephalosporins  tested  were  further  conﬁrmed  for  extended-spectrum
beta-lactamase  (ESBL)-production  by  an  E-strip  test.  Genotypic  virulence  markers,
namely,  hlyD, papC  and  cnf-1, were  detected  by  the  uniplex  PCR  method  and  the
phylogenetic  characterization  was  performed  by  a  multiplex  PCR  assay.
Results:  The  majority  of  the  E.  coli  isolates  belonged  to  the  B2  phylogenetic
group  were  signiﬁcantly  associated  with  ciproﬂoxacin-sensitivity  and  non-ESBL  pro-
duction  (p  <  0.05).  An  increased  prevalence  of  ciproﬂoxacin-sensitive  strains  over
ciproﬂoxacin-resistant  strains  were  observed  among  the  UPEC  isolates  harboring  the
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papC  (72.9%  vs.  40.2%;  p  <  0.001),  hlyD  (43.7%  vs.  21.6%;  p  <  0.001)  and  cnf-1  (30.2%
vs.  12.3%;  p  < 0.05)  genes.  The  presence  of  a  multivirulent  gene  in  the  non-ESBL  E.  coli
strains  (44.5%)  was  signiﬁcantly  higher  (p  <  0.05)  than  in  the  ESBL-producing  strains
(21%).
Conclusions:  Among  the  UPEC  isolates,  the  predominant  B2  phylogenetic  group  was
signiﬁcantly  associated  with  the  ciproﬂoxacin-sensitive  strains,  as  well  as  with  the
non-ESBL  E.  coli  strains.  The  genotypic  virulence  markers  of  UPEC  were  associated
with  ciproﬂoxacin-sensitivity,  and  a  signiﬁcant  number  of  the  non-ESBL  strains  har-
es.  The  relationship  between  the  presence  of  the  virulence
on  was  complex  and  warrants  further  intensive  studies.
vier  Limited  on  behalf  of  King  Saud  Bin  Abdulaziz  University
rights  reserved.
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India from  December  2010  to  February  2013.  Among
the 193  patients  (out-patents,  148  and  in-patients,
45) diagnosed  as  having  symptomatic  UTI,  132bored  multivirulent  gen
genes  and  ESBL  producti
©  2014  Published  by  Else
for  Health  Sciences.  All  
Introduction
Escherichia  coli,  a  normal  commensal  of  the
human body,  becomes  a  highly  adaptive  pathogen
by acquiring  mobile  genetic  elements,  and  they
cause a  wide  range  of  diseases  from  intestinal
to extraintestinal  infections,  including  infections
in the  urinary  tract,  blood  stream  and  central
nervous system  [1]. E.  coli  is the  most  com-
mon cause  of  urinary  tract  infections  (UTI)  in
community and  hospital  settings.  The  severity
of UTI  depends  on  the  virulence  of  the  infect-
ing organism  and  the  susceptibility  of  the  host.
Virulence  factors  (VFs),  such  as  hemolysin  (hly
gene), cytotoxic  necrotizing  factor  type  1  (cnf-
1 gene),  and  pyelonephritis  associated  pili  (pap
gene), play  important  roles  in  the  pathogenicity  of
uropathogenic  E.  coli  (UPEC)  strains  by  overcoming
host defense  mechanisms  to  cause  disease  [2]. The
number  of  multi-drug  resistant  strains  of  E.  coli  has
progressively  increased,  causing  treatment  limita-
tions. An  extremely  limited  range  of  antibacterial
agents remains  as  a  result  of  the  emergence
of ﬂuoroquinolone-resistance  and  ESBL-producing
isolates, ensuring  that  a  simple  case  of  UTI  is
increasingly challenging  [3].  Studies  have  suggested
that in  quinolone  (Q)  and  ﬂuoroquinolone  (FQ)
resistant strains,  fewer  virulence  genes  are  com-
monly encountered  [4].  Phylogenetic  group  speciﬁc
differences  in  quinolone-susceptibility  have  been
noted, with  the  B2  group  strains  showing  higher  fre-
quencies of  susceptibility  than  those  of  the  other
phylogenetic  groups  [5]. The  issue  is complex  in
the case  of  the  ESBL-producing  strains  because
they are  genetically  diverse  and  frequently  co-
exist with  ﬂuoroquinolone-resistance  [6,7]. In  most
parts of  India,  UTI  cases  are  treated  empirically.
With the  increasing  resistance  of  E.  coli  to  antibi-
otics used  for  UTI  treatment,  it  is  pertinent  to
perform  simple  culture  and  sensitivity  testing  of
(
w
s
trine  and  to  document  the  prevalence  of  UPEC  vs.
on-UPEC  in  a region  and  to  characterize  the  vir-
lence genes  and  antibiotic  resistance  of  UPEC.
he complex  relationships  of  the  virulence  prop-
rties and  the  phylogenetic  background  as  well  as
he antibiotic  resistance  of  E.  coli  resulting  from
heir various  interactions  require  further  study.  We
ried to  elucidate  whether  the  lack  of  virulence
actors (VFs)  is directly  associated  with  resistance
r if  resistance  depends  on  a  phylogenetic  distri-
ution or  unknown  factors.  We  analyzed  antibiotic
esistance, the  genotypic  virulence  factors  and  phy-
ogenetic characterization  in  UPEC  isolates.
aterials and methods
ase deﬁnition
rinary  tract  infection  is  deﬁned  as  the  presenta-
ion of  a  combination  of  the  following  symptoms:
i) bacteria  with  ≥104 CFU/ml  count  in  midstream
rine, (ii)  the  presence  of  ≥5  white  blood  cells
WBCs) per  high  power  ﬁeld,  and  (iii)  the  presence
f clinical  signs  and  symptoms  of  UTI  in the  host
ncluding  dysuria,  frequency  or  urgency  of  urina-
ion.
tudy setting
 total  of  193  non-repetitive  E.  coli  strains  were  iso-
ated from  symptomatic  UTI  cases  in  a  tertiary  care
eaching hospital  in  Raichur,  Northern  Karnataka,68.3%)  were  females  and  61  (31.6%)  were  males,
ith a mean  age  of  35.5  ± 18.3  (mean  ±  SD).  The
tudy  was  conducted  with  approval  from  the  Insti-
utional  Ethical  Committee,  and  informed  consent
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cirulence  and  drug  resistance  in  UPEC  
as  obtained  from  the  subjects  willing  to  partici-
ate.
Clean-catch  midstream  urine  samples  were
ollected and  processed  employing  the  semi-
uantitative calibrated  loop  technique,  and  the
igniﬁcant  isolates  (colony  count  ≥105 CFU/ml  of
rine) were  identiﬁed  by  standard  biochemical
eactions [8].
ntimicrobial susceptibility testing
he  antibiotic  susceptibility  testing  was  per-
ormed by  the  Kirby—Bauer’s  Disk  Diffusion
ethod in  accordance  with  the  CLSI  guidelines
9]  using  antibiotic  discs  as  follows:  ampicillin
10 g),  amoxicillin/clavulanic  acid  (20/10  g),
rimethoprim/sulfamethoxazole  (1.25/23.75  g),
iproﬂoxacin  (5  g),  nitrofurantoin,  levoﬂoxacin
5 g),  netilmicin  (30  g),  ceftazidime  (30  g),
efotaxime (30  g),  and  gentamicin  (30  g).  E.  coli
TCC 25922  was  used  as  the  control.
etection of ESBL producing E. coli strains
ll  the  isolates  showing  resistance  to  any  of
he third  generation  cephalosporins,  namely  cef-
azidime  (30  g)  and  cefotaxime  (30  g),  by  the  disk
iffusion  method  were  further  conﬁrmed  for  ESBL
roduction  using  ESBL  E-strip  tests  (AB  BioMerieux,
olna, Sweden),  as  we  described  previously  [10].
etection of virulence genes
he  presence  of  three  types  of  virulence-associated
enes  was  examined  by  PCR  ampliﬁcation  using  the
rimers described  by  Johnson  and  Stell  [11]. The
irulence  genes  consisted  of  hlyD  (hemolysin)  and
nf-1 (cytotoxic  necrotizing  factor  1)  coding  for
oxin secretion  in  UPEC  and  papC  (pyelonephritis
ssociated  pili)  coding  for  bacterial  adhesion.
PEC phylogenetic grouping
he  E.  coli  strains  were  categorized  into  the  four
ajor  phylogenetic  groups  (A,  B1,  B2  and  D)  by
ultiplex  PCR  following  the  protocol  proposed
y Clermont  et  al.,  using  two  virulence  genes
chu A,  encoding  the  heme  transporter  protein  in
. coli  O157:H7  and  yja  A,  initially  identiﬁed  in
he genome  of  E.  coli  K-12)  and  one  DNA  fragment
spE4.C2 [12].tatistical analysis
he  results  were  analyzed  with  descriptive  statis-
ics where  appropriate.  The  Chi-square  and  Fisher’s
t
p
a
(igure  1  Antibiotic  resistant  pattern  of  the  193  UPEC
linical  isolates.
xact  tests  were  used  to  evaluate  the  statistical  sig-
iﬁcance of  the  differences  in  the  results.  A  p-value
f <0.05  was  considered  statistically  signiﬁcant.
he statistical  analysis  was  performed  using  Statis-
ical package  for  the  social  sciences  (SPSS)  v  16.0
oftware.
esult
n  this  study,  the  UPEC  isolates  showed  a high
egree of  resistance  to  ampicillin  (83.2%),
ollowed by  cefotaxime  (54.3%),  trimetho-
rim/sulphamethoxazole  (54.3%),  ceftazidime
53.3%) and  ciproﬂoxacin  (49.2%);  the  least
esistance was  shown  to  netilmicin  (24.3%),  gen-
amicin (28.9%)  and  nitrofurantoin  (38.1%).  In  the
tudy, more  than  50%  of the  E.  coli  strains  were
esistant to  the  third  generation  cephalosporins
sed, and  49.2%  were  resistant  to  ciproﬂoxacin
Fig.  1).
Increased  prevalence  of  ciproﬂoxacin-sensitive
trains  over  ciproﬂoxacin-resistant  strains  were
bserved  among  the  UPEC  isolates  with  the  papC
72.9%  vs.  40.2%;  p  <  0.001),  hlyD  (43.7%  vs.  21.6%;
 <  0.001)  and  cnf-1  (30.2%  vs.  12.3%;  p  <  0.05)
enes. A  highly  signiﬁcant  number  of  ciproﬂoxacin-
ensitive E.  coli  strains  (n  =  78,  81.2%)  harbored
ultivirulent genes  compared  to  the  ciproﬂoxacin-
esistance strains.  Among  the  UPEC  isolates,  the
redominant  phylogenetic  group  was  B2,  with  a
revalence  of  50.7%,  and  the  association  with  the
iproﬂoxacin-sensitive  E.  coli  strains  was  statis-
ically signiﬁcant  (p  =  0004).  The  second  leading
hylogenetic group  A  (27.9%)  was  signiﬁcantly
ssociated with  the  ciproﬂoxacin-resistance  strains
p <  0.001)  of  the  UPEC  isolates,  as  shown  in  Table  1.
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Table  1  Distribution  of  virulence  genes  and  phylogenetic  groups  among  UPEC  in  relation  to  ciproﬂoxacin
susceptibility.
Virulence  genes  &
phylogenetic  group
Total  number  of  Escherichia  coli  strains  tested  (n  = 193)
Ciproﬂoxacin-sensitive  Ciproﬂoxacin-resistant  Chi-square,  p-value*
n  =  96 % n  =  97 %
papC  gene  70  72.9  39  40.2  <0.0001
hly  gene  42  43.7  21  21.6  <0.001
cnf-1  gene  29  30.2  12  12.3  0.002
Multivirulent  gene  (≥2  genes)  78  81.2  17  18.8  <0.0001
Phylogenetic  group
A  16  16.7  38  39.2  0.0007
B1  18  18.7  20  20.6  0.74
B2  59  61.4  39  40.2  0.004
D  3  3.1  0  0  NA
* p-value, ciproﬂoxacin-sensitive vs. ciproﬂoxacin resistance.
Table  2  Distribution  of  virulence  genes  and  phylogenetic  groups  among  UPEC  in  relation  to  ESBL  production.
VF  &  phylogenetic  groups Total  number  of  UPEC  strains  tested  (n  =  193)
Non-ESBL  strainsa ESBL  strains  Chi-square,  p-value*
n  =  155 %  n  =  38  %
hly  gene 52 33.5 11  28.9  0.7
papC  gene 87  56.1 19  50  0.5
cnf-1  gene 35  22.5 7 18.4  0.001
Absence  of  virulence  gene  34  21.9  14  36.8  0.06
Presence  of  any  one  virulence  gene  52  33.5  16  42.1  0.3
Multivirulent  gene  (≥2  genes)  69  44.5  08  21.0  0.009
Phylogenetic  group
A  24  15.4  12  31.5  0.03
B1  18  11.6  5  13.1  0.7
B2  113  72.9  21  55.2  0.04
D  0  0  0  0  0
nsiti
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na Non-ESBL strains include third generation cephalosporin se
* p-value, non-ESBL producing UPEC vs. ESBL producing UPE
Of  the  193  UPEC  strains  studied,  103  (53.3%)
were resistant  to  any  of  the  third  generation
cephalosporin,  of  which  38  (19.7%)  strains  were
positive  for  ESBL  by  the  quantitative  E-strip
method. The  B2  phylogenetic  group  was  predom-
inant in  the  non-ESBL  (72.9%)  and  ESBL  (55.2%)
producing UPEC  strains,  and  the  association  of
group B2  with  the  non-ESBL  strains  was  statis-
tically signiﬁcant  (p  < 0.05).  The  UPEC  isolates
that belonged  to  phylogenetic  group  A  were  more
signiﬁcantly  associated  with  the  ESBL-producing
strains (31.5%)  than  with  the  non-ESBL  strains
(15.4%) (p  =  0.03).  Although,  the  presence  of  any
one virulence  marker  was  higher  in  the  ESBL-
producing strains  (42.1%)  than  in  the  non-ESBL
strains (33.5%),  the  presence  of  a  multivirulent
c
w
w
rve and ESBL E-strip negative strains.
ene  was  signiﬁcantly  higher  (p  <  0.05)  in  the  non-
SBL strains  (44.5%)  than  in  the  ESBL-producing
trains (21%).  Of  the  3  virulence  genes  tested,  only
nf-1 showed  a signiﬁcant  difference  (p  =  0.001)
etween  the  non-ESBL  (22.5%)  and  the  ESBL-
roducing (18.4%)  strains,  as  depicted  in  Table  2.
iscussion
n  this  study,  we  observed  that  the  B2  phyloge-
etic group  was  signiﬁcantly  associated  with  the
iproﬂoxacin-sensitive  E.  coli  strains  as  well  as
ith the  non-ESBL  strains.  Phylogenetic  group  A
as signiﬁcantly  associated  with  the  ciproﬂoxacin-
esistant and  ESBL-producing  E.  coli  strains.  The
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rirulence  and  drug  resistance  in  UPEC  
iproﬂoxacin-sensitive  strains  harbored  virulence
enes at  a  higher  frequency;  however,  a  complex
ssociation was  noticed  between  ESBL-production
nd the  presence  of  virulence  genes  in  the  UPEC
solates.
The initial  step  in  the  pathogenesis  of  UPEC  is
dhesion. The  expression  of  adhesive  organelles
uch as  Type  1  and  P  pili  allow  UPEC  to  bind  and
nvade host  cells.  The  subsequent  step  is the  devel-
pment  of  an  array  of  toxins,  including  hemolysin
nd cytotoxic  necrotizing  factor  1  that  provide
PEC with  the  ability  to  cause  tissue  damage,  facili-
ate bacterial  dissemination,  release  host  nutrients
nd disable  immune  effector  cells  [13].
The virulence  factors  of  extraintestinal
athogenic E.  coli  (ExPEC)  such  as  hemolysin
hly gene),  cytotoxic  necrotizing  factor  1  (cnf-1),
 pili  F13  (pap  gene),  and  S  family  adhesins  (Sfa
ene) form  clusters,  named  ‘pathogenicity  islands’
PAI).  They  are  typically  located  in  chromosomes
nd also  in  plasmid,  and  they  comprise  a  large
egment of  the  DNA  associated  with  the  tRNA  gene.
dditionally,  the  PAI  contribute  a  remarkable  bene-
t to  bacterial  ﬁtness  by  allowing  the  transmission
f genes  that  could  provide  a  survival  advantage
o bacteria  or  to  its  ability  to  cause  disease.  In
his study,  we  selected  three  representative  PAI
irulence  genes,  hlyD,  papC  and  cnf-1.
In our  study,  the  UPEC  strains  showed  a  higher
revalence of  resistance  to  the  antibiotics  com-
only  used  for  the  treatment  of  UTI,  which  was
n agreement  with  the  reports  of  recent  studies
14,15].  The  UPEC  strains  showed  the  least  resis-
ance to  the  aminoglycosides,  and  among  them,
etilmicin (24.3%)  was  more  effective  than  gen-
amicin  (28.8%)  in  sensitivity.  Similar  to  our  results,
hitnis  et  al.  observed  that  the  highest  number  of
ram-negative  bacilli  were  resistant  to  ampicillin
83.2%), and  the  lowest  number  were  resistant  to
etilmicin  (24.3%)  [16].
In our  study,  a  lower  prevalence  of  the  three
irulence genes  studied  (hly  gene,  cnf-1  gene  and
apC gene)  was  signiﬁcantly  associated  (p  <  0.05)
ith the  ciproﬂoxacin-resistant  E.  coli  strains.  Sim-
lar to  our  ﬁndings,  Horcajada  et  al.  reported
hat quinolone  resistance  was  associated  with  a
igniﬁcantly  decreased  prevalence  of  three  viru-
ence  factors  including  sfa,  hly  and  cnf-1  [17].
ohnson et  al.  showed  that  the  presence  of  P  ﬁm-
riae and  hemolysin  were  signiﬁcantly  associated
ith a  lack  of  antimicrobial  resistance  [18]. The
ower incidence  of  papC,  hly  and  cnf-1  among
he ciproﬂoxacin-resistant  B2  strains  appears  to
esult from  the  loss  of  the  corresponding  PAI  that
ppeared  without  gyrA  mutation  and  without  any
f the  antibiotics  in  the  medium  indicating  the
p
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nstability  of  PAI.  This  PAI  instability  could  be  exac-
rbated by  several  stimuli,  of  which  the  presence
f ciproﬂoxacin  might  be  only  one  [19].
Soto et  al.  investigated  the  capacity  of  the
uinolones to  induce  the  loss  of  virulence  factors
uch as  hemolysin  (hly  gene),  cytotoxic  necrotiz-
ng factor  1  (cnf-1  gene),  P  ﬁmbriae  (pap  gene),
nd the  autotransporter  (sat  gene)  in  uropathogenic
. coli  strains.  They  found  that  all  the  strains  lost
emolytic  capacity  in  subinhibitory  concentrations
f ciproﬂoxacin,  showing  a  partial  or  total  loss  of
he PAI  containing  the  hly  and  cnf-1  genes.  They
bserved  no  spontaneous  loss  of  PAIs  on  incubation
n the  absence  of  quinolones  in  the  wild  type  or
utant  E. coli  strains  [4].
The co-existence  of  ESBL-production  and
iproﬂoxacin-resistance  was  observed  in  49.2%  of
he E.  coli  isolates  in  the  study.  The  association
f ESBL-producing  strains  with  resistance  to  other
lasses  of  antibiotics  such  as  the  ﬂuoroquinolones
FQ) was  reported  by  Paterson  et  al.  [20]  and
autenbach et  al.  [21].
We found  that,  among  the  urinary  E.  coli  isolates,
iproﬂoxacin-resistance  was  associated  with  signif-
cant shifts  in  the  phylogenetic  distribution  and
irulence  genotypes.  The  shifts  observed  among  the
iproﬂoxacin-resistant  E.  coli  isolates  were  toward
he non-B2  phylogenetic  groups  (notably,  group  A).
ur results  are  in  complete  agreement  with  the
ndings  of  Johnson  et  al.,  who  observed  an  associ-
tion of  ciproﬂoxacin  resistance  with  phylogenetic
roup A  and  ciproﬂoxacin  sensitivity  with  phylo-
enetic  group  B2  [22]. Piatti  et  al.  also  observed
hat B2  being  the  frequent  phylogenetic  group,
as signiﬁcantly  higher  among  susceptible  strains
han the  resistant  strains  [19].  Houdouin  et  al.  pro-
osed that  the  group  A  strains  in  the  fecal  ﬂora
ould have  developed  from  a greater  exposure  to
ntibiotics.  The  quinolone-resistant  isolates  might
e mutants  of  quinolone-sensitive  strains,  and  the
trains might  have  lost  their  PAI  in  exchange  for
esistance  [23].
The  shift  in  phylogenetic  distribution  was  con-
istent  with  the  hypothesis  of  Johnson  et  al.  that,
lthough  VFs  and  antibiotic  resistance  each  might
onfer increased  ﬁtness  in  extraintestinal  infec-
ions,  they  might  do  so  via  mutually  exclusive
athways and  in  distinct  populations.  In healthy
osts with  little  antibiotic  exposure,  a  robust  VF
epertoire might  be  essential  to  a pathogen  over-
oming intact  host  defenses,  whether  antibiotic
esistance is  present  or  not.  Conversely,  in  com-
romised  hosts,  who  might  have  been  exposed
o many  antibiotics  as  well  as  having  weakened
efenses, antibiotic  resistance  might  provide  a  sub-
tantial advantage  to  the  pathogen,  whereas  a
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more  robust  arsenal  of  VFs  might  be  unnecessary
[23].
This  hypothesis  might  not  be  true  for  all  the
isolates, especially  for  the  ST131  E.  coli  isolate.
The E.  coli  ST131  isolates  signiﬁcantly  exceeded
the non-ST131  isolates  in  the  extent  of  the  resis-
tance and/or  the  virulence  proﬁle.  Colpan  et  al.
reported  that,  in  the  FQ-Sensitive  E.  coli  isolates,
the virulence  factor  scores  were  high  regardless  of
the ST131  genotype;  in  the  FQ-resistant  and  ESBL
isolates,  the  virulence  factor  scores  were  much
higher in  the  ST131  than  in  the  non-ST131  isolates
[24].  The  ST131  E.  coli  isolate  appears  to  com-
bine resistance  and  virulence,  which  to  some  extent
are mutually  exclusive.  This  combination  of  resis-
tance  and  virulence  might  give  ST131  a  competitive
advantage over  other  E.  coli,  promoting  its  clonal
expansion  and  dominance  over  less  virulent  and/or
more susceptible  clones  [25].
In  our  study,  the  ESBL-producing  UPEC  isolates
were predominantly  observed  in  the  B2  phyloge-
netic group,  and  this  ﬁnding  is  in  agreement  with  a
previous report  by  Demirel  et  al.  [26].  We  observed
an increased  prevalence  of  the  hlyD  and  papC  genes
in the  non-ESBL  strains  compared  to  the  ESBL-
producing strains;  however,  the  difference  was  not
statistically  signiﬁcant,  and  the  cnf-1  gene  showed
a signiﬁcant  association  with  the  non-ESBL  strains.
In previous  studies,  hemolysin,  cytotoxic  necrotiz-
ing factor  1  (CNF1)  and  secreted  autotransporter
toxin (SAT)  have  been  shown  to  be  less  prevalent
in ESBL-producing  E.  coli  strains  than  in  susceptible
isolates [13,27]. In  a  recent  study,  Qin  et  al.  showed
that the  adhesion  genes  were  more  prevalent  in
non-ESBL  producing  strains  than  in  ESBL-producing
strains [28].  Pathogens  acquire  resistance  deter-
minants  and  express  multi-resistant  phenotypes  at
the expense  of  their  virulence  properties  [22].  Con-
trary to  our  ﬁndings,  Jadhav  et  al.  reported  that  the
ESBL-producing  isolates  were  frequently  associated
with hemolytic  phenotypes  at  a  higher  rate  (65.6%)
than were  the  non-ESBL  E.  coli  strains  (58.5%)  [29].
A major  part  of  our  observation  strengthens  the
argument  that  ciproﬂoxacin-resistant  UPEC  strains
are less  virulent  than  ciproﬂoxacin-susceptible
strains. Our  observation  is  consistent  with  ear-
lier reports  and  suggests  that  antibiotic  resistant
strains have  less  virulent  properties.  The  relation-
ship between  the  presence  of  virulence  genes  and
ESBL production  is  complex  and  requires  further
intensive studies.Funding
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